The Professor Emeritus at the Pierre and Marie Curie University, Paris was a patron of microbiology and antimicrobial stewardship. He died on March 27, 2020.

Among many thousands of deaths, the COVID-19 pandemic has claimed the life of world renowned infectious disease expert Jacques Acar. Acar is revered for his passionate contribution to the fight against antimicrobial resistance. The polymath was hospitalised on Mar 20, 2020 upon his return from the USA after attending a congress. On March 27, 2020, Acar succumbed to the rapid evolution of COVID-19.

"After a life entirely dedicated to the fight against microbes, it was a virus that took him", writes his colleague Jacques Mokhbat from the Lebanese American University, in an obituary to the French daily newspaper, *L\'Orient-Le Jour*.

Born on April 13, 1931 in Dakar, Senegal, to Lebanese parents, Acar finished his secondary studies in 1948 at the Notre-Dame de Jamhour College, Lebanon, before leaving to settle in France. Acar\'s first interest in infectious diseases comes from the memories of times when colonial Senegal was under the grips of bubonic plague and yellow fever. "The epidemic of yellow fever was still in all memories: with all the fear and the 12 months of the city quarantine---no boats and no relation with the rest of the world", recalled Acar in 2018. "The discussions in my family were passionate: infectious diseases were part of the blend of nature, beauty and dread", added Acar.

After graduating in 1954 from the Faculty of Medicine in Paris, Acar served as a military physician in sub-Saharan Africa for the next 3 years. His apprenticeship in various fields of medicine culminated with him becoming head of the clinic of infectious diseases at the Claude Bernard Hospital in Paris in 1962. Then his first steps into research, antimicrobial resistance in particular, began in association with Yves Chabbert at the Pasteur Institute and Maxwell Finland at Harvard. Since then Acar\'s career progressed with long-term influential positions at Hôpital Saint-Joseph (1966), Hôpital Broussais (since 1972 until his death), and Pierre and Marie Curie University (since 1973 until his death), all in Paris. Till his passing he inspired many generations of clinical microbiologists.

"I first visited his lab as a resident and soon after meeting him, I knew I am going to pursue clinical microbiology", recalled Emmanuelle Cambau, a colleague of Acar, who knew him for over three decades. Currently a professor of mycobacterial microbiology at Hôpital Lariboisìre Université de Paris, Cambau is still amazed at Acar\'s inspiration towards the combination of research and clinical work. "In the morning we\'d stop by the lab, then we\'d go to clinic, then we\'d go back to the lab to discuss cases with other colleagues, and in the afternoon we\'d do research", Cambau told *The Lancet Infectious Diseases*.

Acar was one of the prime figures behind the establishment of several multi-institutional and multinational collaborations across the globe. In the 1970s, along with the Harvard physician, Thomas O\'Brien, he established one of the pioneering systems for the surveillance of nosocomial antimicrobial resistance. When the late physician [Stuart Levy](https://doi.org/10.1016/S1473-3099(19)30517-1){#interrefs10} founded the Alliance for the Prudent Use of Antibiotics in 1981, Acar was on its scientific advisory board.

Acar served as a founder member at the International Society of Infectious Diseases (1988--2020) and first President of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, 1993--1995). Then under the auspices of ESCMID, working with Fernando Baquero (Ramón y Cajal University Hospital, Spain) and the late [Giuseppe Cornaglia](https://doi.org/10.1016/S1473-3099(20)30306-6){#interrefs20} (University of Verona, Italy), Acar established various expert groups to study bacterial resistance to antibiotics.

Since the 1990s, Acar worked with the ad hoc Committee at the World Organization for Animal Health as well as the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance to advocate for the prudent use of antibiotics: surveillance of antimicrobial resistance and of consumption of critically important antibiotics for animal husbandry. Acar was one of the prominent supporters of the Program for Monitoring Emerging Diseases, one of the largest publicly available emerging diseases and outbreak reporting systems in the world.

"He brought great bonhomie and joie de vivre to the role", noted Acar\'s colleague Laura Piddock (University of Birmingham, UK). "He has left a great legacy for the community" she added.

Acar is known among his peers for his baritone voice and deep passion for history, travel, culture, and music. He went on to take up opera lessons and perform on stage. "\[Acar\] enjoyed a pleasant personality and interacted in a professional and respectful way with his peers. Our social gatherings over dinners in all these events were pleasant and entertaining and, at the same time, enriching with discussions not only on microbiology and infectious diseases" recalled Ghassan Matar (American University of Beirut, Lebanon).

Acar leaves behind his wife Elisabeth de Langre, four sons, and ten grandchildren.
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